Haleon plc HLN
NYSE
$9.44-0.06 (-0.63%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Excedrin today announced My Little Headache, a digital pet experience inspired by the resurgence of nostalgic virtual pets, bringing the real-life chaos of a headache to life while introducing Excedrin Rapid Relief. The new product features patented Fast Release Technology and starts providing relief from tough pain in as little as 15 minutes, all in an aspirin-free and caffeine-free formula.
Big Tech is pouring an estimated $700b into AI infrastructure this year, and global healthcare is a key proving ground for whether that spend pays off. UK investors are watching closely because hospitals, drug makers and software providers that can turn AI into real efficiency gains may reshape healthcare economics. This article highlights three AI focused healthcare stocks from our screener to help you evaluate the landscape early. The stocks highlighted below are just a small sample of the...
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.
HLN is in the latest 13F portfolio of 1 of the gurus we follow.
